Prevalence and clinical significance of solitary pulmonary sub-segmental microembolism

BACKGROUND: Solitary pulmonary microembolism is rarely discussed as a distinct diagnostic entity. The purpose of this investigation was to determine the prevalence and clinical significance of embolism limited to subsegmental branches in a group of patients discharged from hospital on anticoagulants with a diagnosis of pulmonary embolism based on ventilation-perfusion imaging followed by selective angiography. MATERIAL AND METHODS: Of 29 consecutive patients with classic signs of pulmonary embolism at angiography, we identified a subgroup of 5 patients with sub-segmental embolism, which was solitary in all cases. RESULTS: Clinical presentation included chest pain (2/5), shortness of breath (2/5, or hypoxemia (1/5). Chest X-rays were normal (2/5), or showed pulmonary oedema (1/5) or atelectasis with (1/5), or without (1/5) pleural effusion. VQ imaging patterns included small subsegmental mismatch (1/5), one segment mismatch (1/5), single (1/5) or triple (2/5) match. The site and size of the microemboli found at angiography were incompatible with the location and severity of symptoms in 4/5 (80%) patients, and with location and extent of Chest X-ray findings and with VQ patterns in all patients. VQ abnormalities were either either disproportionably larger or were non congruent with the vascular territory compromised by the subsegmental embolus. CONCLUSIONS: Sub-segmental pulmonary micro-emboli were always solitary, and not uncommon, comprising 17% of all patients with pulmonary embolism. The location and size of the emboli were inconsistent with clinical, Chest X-ray and scintigraphic findings, suggesting that isolated microemboli are a serendipitous finding, of no clinical significance

Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine

PURPOSE Key to achieving better population-based outcomes for patients with lung cancer is the improvement of medical imaging and nuclear medicine infrastructure globally. This paper aims to outline why and spark relevant health systems strengthening. METHODS The paper synthesizes the global lung cancer landscape, imaging referral guidelines (including resource-stratified ones), the reliance of TNM staging upon imaging, relevant multinational health technology assessments, and precisely how treatment selection and in turn patient outcomes hinge upon imaging findings. The final discussion presents data on current global gaps in both diagnostics (including imaging) and therapies and how, informed by such data, improved population-based outcomes are tangible through strategic planning. RESULTS Imaging findings are central to appropriate lung cancer patient management and can variably lead to life-prolonging interventions and/or to life-enhancing palliative measures. Early-stage lung cancer can be treated with curative intent but, unfortunately, most patients with lung cancer still present at advanced stages and many patients lack access to both diagnostics and therapies. Furthermore, half of lung cancer cases occur in low- and middle-income countries. The role of medical imaging and nuclear medicine in lung cancer management, as outlined herein, may help inform strategic planning. CONCLUSION Lung cancer is the number one cancer killer worldwide. The essential role that medical imaging and nuclear medicine play in early diagnosis and disease staging cannot be overstated, pivotal in selecting the many patients for whom measurably improved outcomes are attainable. Prevention synergized with patient-centered, compassionate, high-quality lung cancer management provision mandate that strategic population-based planning, including universal health coverage strategies, should extend well beyond the scope of disease prevention to include both curative and noncurative treatment options for the millions afflicted with lung cancer

A simple and innovative device to measure arm volume at home for patients with lymphedema after breast cancer

A B S T R A C T Purpose We designed an arm volumeter specifically for home use based on the water displacement method. The objective of this study was to determine its accuracy and precision, and compare it with a standard volumeter used in lymphedema clinics worldwide. Patients and Methods Using a standard model hospital volumeter and our own device, we took three consecutive measurements of 11 specially cast cylinders, which had known volumes ranging from 10mL to 4 L, and measurements of both arms of 15 volunteers. Results Measurements with both volumeters were highly accurate (R 2 ϭ 0.9999) when compared with the known volumes of the cast cylinders, and were strongly correlated (R 2 ϭ 0.9974) when each arm volume was compared between volumeters. Measurements with our volumeter were more precise both with the cylinders (average standard deviation [SD], 3.2 v 8 mL; P ϭ .0553) and with the arms (average SD, 11.1 v 19 mL; P ϭ .0034). Whereas the standard volumeter is expensive, fragile (acrylic), and prone to leaks, our volumeter is inexpensive, virtually indestructible, leak proof, and suitable for home use. Conclusion Arm volumes can be measured quickly and accurately at home using a simple, inexpensive, and robust device based on water displacement. Readily accessible arm volumetry at home may have widespread influence on the management of lymphedema after breast cancer